Literature DB >> 16135534

Analysis of an adult Duchenne muscular dystrophy population.

A E Parker1, S A Robb, J Chambers, A C Davidson, K Evans, J O'Dowd, A J Williams, R S Howard.   

Abstract

BACKGROUND: Advances in management have led to increasing numbers of patients with Duchenne muscular dystrophy (DMD) reaching adulthood. Older patients with DMD are necessarily severely disabled, and their management presents particular practical issues. AIM: To review the management of a late adolescent and adult DMD population, and to identify areas in which the present service provisions may be inadequate to their needs.
DESIGN: Retrospective review.
METHODS: We studied 25 patients with DMD referred to an adult neuromuscular clinic over a 7-year period. Clinical details were obtained retrospectively, from case notes or direct observations.
RESULTS: There were 24 males and one symptomatic female carrier. Nine patients died during the observation period. There was no significant correlation between age of wheelchair confinement and age of death. Sixteen patients received non-invasive positive pressure support. Twelve attended mainstream schools and 12, residential special schools. All the patients lived at home for some or all of the time, when their main carers were either one or both of the parents. The most striking difficulties were with the provision of practical aids, including appropriate hoists and belts, feeding and toileting aids, and the conversion of accommodation. Patients rarely wished to discuss the later stages of their disease, and death was often more precipitate than expected. Death usually occurred outside hospital and the final cause was often difficult to establish. DISCUSSION: Adult patients with DMD develop progressive impairment, due to respiratory, orthopaedic and general medical factors. However, the particular areas of difficulty in this study often reflected inadequate and poorly directed social and medical support, illustrating the need for improvements in the structure, co-ordination and breadth of rehabilitation services for adult patients with DMD.

Entities:  

Mesh:

Year:  2005        PMID: 16135534     DOI: 10.1093/qjmed/hci113

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  14 in total

1.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  Occurrence of symptoms in different stages of Duchenne muscular dystrophy and their impact on social participation.

Authors:  Saskia L S Houwen-van Opstal; Lotte Heutinck; Merel Jansen; Yvonne D Krom; Edith H C Cup; Jos G M Hendriksen; Michel A A P Willemsen; Jan J G M Verschuuren; Erik H Niks; Imelda J M de Groot
Journal:  Muscle Nerve       Date:  2021-09-09       Impact factor: 3.852

3.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12

4.  Multiple poloxamers increase plasma membrane repair capacity in muscle and nonmuscle cells.

Authors:  Thomas A Kwiatkowski; Aubrey L Rose; Rachel Jung; Ana Capati; Diana Hallak; Rosalie Yan; Noah Weisleder
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-20       Impact factor: 4.249

Review 5.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

6.  Risk of fracture in patients with muscular dystrophies.

Authors:  S Pouwels; A de Boer; H G M Leufkens; W E J Weber; C Cooper; H A W van Onzenoort; F de Vries
Journal:  Osteoporos Int       Date:  2013-08-15       Impact factor: 4.507

7.  Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the Neuromuscular Centre Ulm.

Authors:  Kurt H Wollinsky; Bernd Kutter; Peter M Geiger
Journal:  Acta Myol       Date:  2012-12

Review 8.  Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.

Authors:  Maman Joyce Dogba; Frank Rauch; Erin Douglas; Christophe Bedos
Journal:  Health Qual Life Outcomes       Date:  2014-10-25       Impact factor: 3.186

Review 9.  Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.

Authors:  Jacqueline N Robinson-Hamm; Charles A Gersbach
Journal:  Hum Genet       Date:  2016-08-20       Impact factor: 4.132

10.  Prospective observational cohort study of patients with weaning failure admitted to a specialist weaning, rehabilitation and home mechanical ventilation centre.

Authors:  Denise Mifsud Bonnici; Thomas Sanctuary; Alex Warren; Patrick B Murphy; Joerg Steier; Philip Marino; Hina Pattani; Ben C Creagh-Brown; Nicholas Hart
Journal:  BMJ Open       Date:  2016-03-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.